Medical Care
Global Surgical Treatment of Dermatophytosis Market Research Report 2025
- May 12, 25
- ID: 234297
- Pages: 87
- Figures: 86
- Views: 6
The global market for Surgical Treatment of Dermatophytosis was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Surgical Treatment of Dermatophytosis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Surgical Treatment of Dermatophytosis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Surgical Treatment of Dermatophytosis in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Surgical Treatment of Dermatophytosis include Bausch Health, Galderma S.A., Novartis AG, Pfizer, Inc., Moberg Pharma AB, Bayer AG, Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Medimetriks Pharmaceuticals, Inc., Sanofi S.A., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Surgical Treatment of Dermatophytosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Surgical Treatment of Dermatophytosis.
The Surgical Treatment of Dermatophytosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Surgical Treatment of Dermatophytosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Surgical Treatment of Dermatophytosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch Health
Galderma S.A.
Novartis AG
Pfizer, Inc.
Moberg Pharma AB
Bayer AG
Dr. Reddy’s Laboratories Ltd.
Cipla Ltd.
Medimetriks Pharmaceuticals, Inc.
Sanofi S.A.
GlaxoSmithKline Plc.
Teva Pharmaceutical industries Ltd.
Cardinal Health Inc.
Viatris Inc.
Almirall, S.A
Segment by Type
Dermatophytic Onychomycosis Therapeutic Lasers
Photodynamic Therapy
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Surgical Treatment of Dermatophytosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Surgical Treatment of Dermatophytosis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Surgical Treatment of Dermatophytosis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Surgical Treatment of Dermatophytosis in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Surgical Treatment of Dermatophytosis include Bausch Health, Galderma S.A., Novartis AG, Pfizer, Inc., Moberg Pharma AB, Bayer AG, Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Medimetriks Pharmaceuticals, Inc., Sanofi S.A., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Surgical Treatment of Dermatophytosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Surgical Treatment of Dermatophytosis.
The Surgical Treatment of Dermatophytosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Surgical Treatment of Dermatophytosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Surgical Treatment of Dermatophytosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch Health
Galderma S.A.
Novartis AG
Pfizer, Inc.
Moberg Pharma AB
Bayer AG
Dr. Reddy’s Laboratories Ltd.
Cipla Ltd.
Medimetriks Pharmaceuticals, Inc.
Sanofi S.A.
GlaxoSmithKline Plc.
Teva Pharmaceutical industries Ltd.
Cardinal Health Inc.
Viatris Inc.
Almirall, S.A
Segment by Type
Dermatophytic Onychomycosis Therapeutic Lasers
Photodynamic Therapy
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Surgical Treatment of Dermatophytosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Surgical Treatment of Dermatophytosis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Dermatophytic Onychomycosis Therapeutic Lasers
1.2.3 Photodynamic Therapy
1.3 Market by Application
1.3.1 Global Surgical Treatment of Dermatophytosis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Surgical Treatment of Dermatophytosis Market Perspective (2020-2031)
2.2 Global Surgical Treatment of Dermatophytosis Growth Trends by Region
2.2.1 Global Surgical Treatment of Dermatophytosis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Surgical Treatment of Dermatophytosis Historic Market Size by Region (2020-2025)
2.2.3 Surgical Treatment of Dermatophytosis Forecasted Market Size by Region (2026-2031)
2.3 Surgical Treatment of Dermatophytosis Market Dynamics
2.3.1 Surgical Treatment of Dermatophytosis Industry Trends
2.3.2 Surgical Treatment of Dermatophytosis Market Drivers
2.3.3 Surgical Treatment of Dermatophytosis Market Challenges
2.3.4 Surgical Treatment of Dermatophytosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Surgical Treatment of Dermatophytosis Players by Revenue
3.1.1 Global Top Surgical Treatment of Dermatophytosis Players by Revenue (2020-2025)
3.1.2 Global Surgical Treatment of Dermatophytosis Revenue Market Share by Players (2020-2025)
3.2 Global Surgical Treatment of Dermatophytosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Surgical Treatment of Dermatophytosis Revenue
3.4 Global Surgical Treatment of Dermatophytosis Market Concentration Ratio
3.4.1 Global Surgical Treatment of Dermatophytosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Surgical Treatment of Dermatophytosis Revenue in 2024
3.5 Global Key Players of Surgical Treatment of Dermatophytosis Head office and Area Served
3.6 Global Key Players of Surgical Treatment of Dermatophytosis, Product and Application
3.7 Global Key Players of Surgical Treatment of Dermatophytosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Surgical Treatment of Dermatophytosis Breakdown Data by Type
4.1 Global Surgical Treatment of Dermatophytosis Historic Market Size by Type (2020-2025)
4.2 Global Surgical Treatment of Dermatophytosis Forecasted Market Size by Type (2026-2031)
5 Surgical Treatment of Dermatophytosis Breakdown Data by Application
5.1 Global Surgical Treatment of Dermatophytosis Historic Market Size by Application (2020-2025)
5.2 Global Surgical Treatment of Dermatophytosis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Surgical Treatment of Dermatophytosis Market Size (2020-2031)
6.2 North America Surgical Treatment of Dermatophytosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Surgical Treatment of Dermatophytosis Market Size by Country (2020-2025)
6.4 North America Surgical Treatment of Dermatophytosis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Surgical Treatment of Dermatophytosis Market Size (2020-2031)
7.2 Europe Surgical Treatment of Dermatophytosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Surgical Treatment of Dermatophytosis Market Size by Country (2020-2025)
7.4 Europe Surgical Treatment of Dermatophytosis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Surgical Treatment of Dermatophytosis Market Size (2020-2031)
8.2 Asia-Pacific Surgical Treatment of Dermatophytosis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Surgical Treatment of Dermatophytosis Market Size by Region (2020-2025)
8.4 Asia-Pacific Surgical Treatment of Dermatophytosis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Surgical Treatment of Dermatophytosis Market Size (2020-2031)
9.2 Latin America Surgical Treatment of Dermatophytosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Surgical Treatment of Dermatophytosis Market Size by Country (2020-2025)
9.4 Latin America Surgical Treatment of Dermatophytosis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Surgical Treatment of Dermatophytosis Market Size (2020-2031)
10.2 Middle East & Africa Surgical Treatment of Dermatophytosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Surgical Treatment of Dermatophytosis Market Size by Country (2020-2025)
10.4 Middle East & Africa Surgical Treatment of Dermatophytosis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Surgical Treatment of Dermatophytosis Introduction
11.1.4 Bausch Health Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.1.5 Bausch Health Recent Development
11.2 Galderma S.A.
11.2.1 Galderma S.A. Company Details
11.2.2 Galderma S.A. Business Overview
11.2.3 Galderma S.A. Surgical Treatment of Dermatophytosis Introduction
11.2.4 Galderma S.A. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.2.5 Galderma S.A. Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Surgical Treatment of Dermatophytosis Introduction
11.3.4 Novartis AG Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.3.5 Novartis AG Recent Development
11.4 Pfizer, Inc.
11.4.1 Pfizer, Inc. Company Details
11.4.2 Pfizer, Inc. Business Overview
11.4.3 Pfizer, Inc. Surgical Treatment of Dermatophytosis Introduction
11.4.4 Pfizer, Inc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.4.5 Pfizer, Inc. Recent Development
11.5 Moberg Pharma AB
11.5.1 Moberg Pharma AB Company Details
11.5.2 Moberg Pharma AB Business Overview
11.5.3 Moberg Pharma AB Surgical Treatment of Dermatophytosis Introduction
11.5.4 Moberg Pharma AB Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.5.5 Moberg Pharma AB Recent Development
11.6 Bayer AG
11.6.1 Bayer AG Company Details
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Surgical Treatment of Dermatophytosis Introduction
11.6.4 Bayer AG Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.6.5 Bayer AG Recent Development
11.7 Dr. Reddy’s Laboratories Ltd.
11.7.1 Dr. Reddy’s Laboratories Ltd. Company Details
11.7.2 Dr. Reddy’s Laboratories Ltd. Business Overview
11.7.3 Dr. Reddy’s Laboratories Ltd. Surgical Treatment of Dermatophytosis Introduction
11.7.4 Dr. Reddy’s Laboratories Ltd. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.7.5 Dr. Reddy’s Laboratories Ltd. Recent Development
11.8 Cipla Ltd.
11.8.1 Cipla Ltd. Company Details
11.8.2 Cipla Ltd. Business Overview
11.8.3 Cipla Ltd. Surgical Treatment of Dermatophytosis Introduction
11.8.4 Cipla Ltd. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.8.5 Cipla Ltd. Recent Development
11.9 Medimetriks Pharmaceuticals, Inc.
11.9.1 Medimetriks Pharmaceuticals, Inc. Company Details
11.9.2 Medimetriks Pharmaceuticals, Inc. Business Overview
11.9.3 Medimetriks Pharmaceuticals, Inc. Surgical Treatment of Dermatophytosis Introduction
11.9.4 Medimetriks Pharmaceuticals, Inc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.9.5 Medimetriks Pharmaceuticals, Inc. Recent Development
11.10 Sanofi S.A.
11.10.1 Sanofi S.A. Company Details
11.10.2 Sanofi S.A. Business Overview
11.10.3 Sanofi S.A. Surgical Treatment of Dermatophytosis Introduction
11.10.4 Sanofi S.A. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.10.5 Sanofi S.A. Recent Development
11.11 GlaxoSmithKline Plc.
11.11.1 GlaxoSmithKline Plc. Company Details
11.11.2 GlaxoSmithKline Plc. Business Overview
11.11.3 GlaxoSmithKline Plc. Surgical Treatment of Dermatophytosis Introduction
11.11.4 GlaxoSmithKline Plc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.11.5 GlaxoSmithKline Plc. Recent Development
11.12 Teva Pharmaceutical industries Ltd.
11.12.1 Teva Pharmaceutical industries Ltd. Company Details
11.12.2 Teva Pharmaceutical industries Ltd. Business Overview
11.12.3 Teva Pharmaceutical industries Ltd. Surgical Treatment of Dermatophytosis Introduction
11.12.4 Teva Pharmaceutical industries Ltd. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.12.5 Teva Pharmaceutical industries Ltd. Recent Development
11.13 Cardinal Health Inc.
11.13.1 Cardinal Health Inc. Company Details
11.13.2 Cardinal Health Inc. Business Overview
11.13.3 Cardinal Health Inc. Surgical Treatment of Dermatophytosis Introduction
11.13.4 Cardinal Health Inc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.13.5 Cardinal Health Inc. Recent Development
11.14 Viatris Inc.
11.14.1 Viatris Inc. Company Details
11.14.2 Viatris Inc. Business Overview
11.14.3 Viatris Inc. Surgical Treatment of Dermatophytosis Introduction
11.14.4 Viatris Inc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.14.5 Viatris Inc. Recent Development
11.15 Almirall, S.A
11.15.1 Almirall, S.A Company Details
11.15.2 Almirall, S.A Business Overview
11.15.3 Almirall, S.A Surgical Treatment of Dermatophytosis Introduction
11.15.4 Almirall, S.A Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.15.5 Almirall, S.A Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Surgical Treatment of Dermatophytosis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Dermatophytic Onychomycosis Therapeutic Lasers
1.2.3 Photodynamic Therapy
1.3 Market by Application
1.3.1 Global Surgical Treatment of Dermatophytosis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Surgical Treatment of Dermatophytosis Market Perspective (2020-2031)
2.2 Global Surgical Treatment of Dermatophytosis Growth Trends by Region
2.2.1 Global Surgical Treatment of Dermatophytosis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Surgical Treatment of Dermatophytosis Historic Market Size by Region (2020-2025)
2.2.3 Surgical Treatment of Dermatophytosis Forecasted Market Size by Region (2026-2031)
2.3 Surgical Treatment of Dermatophytosis Market Dynamics
2.3.1 Surgical Treatment of Dermatophytosis Industry Trends
2.3.2 Surgical Treatment of Dermatophytosis Market Drivers
2.3.3 Surgical Treatment of Dermatophytosis Market Challenges
2.3.4 Surgical Treatment of Dermatophytosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Surgical Treatment of Dermatophytosis Players by Revenue
3.1.1 Global Top Surgical Treatment of Dermatophytosis Players by Revenue (2020-2025)
3.1.2 Global Surgical Treatment of Dermatophytosis Revenue Market Share by Players (2020-2025)
3.2 Global Surgical Treatment of Dermatophytosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Surgical Treatment of Dermatophytosis Revenue
3.4 Global Surgical Treatment of Dermatophytosis Market Concentration Ratio
3.4.1 Global Surgical Treatment of Dermatophytosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Surgical Treatment of Dermatophytosis Revenue in 2024
3.5 Global Key Players of Surgical Treatment of Dermatophytosis Head office and Area Served
3.6 Global Key Players of Surgical Treatment of Dermatophytosis, Product and Application
3.7 Global Key Players of Surgical Treatment of Dermatophytosis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Surgical Treatment of Dermatophytosis Breakdown Data by Type
4.1 Global Surgical Treatment of Dermatophytosis Historic Market Size by Type (2020-2025)
4.2 Global Surgical Treatment of Dermatophytosis Forecasted Market Size by Type (2026-2031)
5 Surgical Treatment of Dermatophytosis Breakdown Data by Application
5.1 Global Surgical Treatment of Dermatophytosis Historic Market Size by Application (2020-2025)
5.2 Global Surgical Treatment of Dermatophytosis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Surgical Treatment of Dermatophytosis Market Size (2020-2031)
6.2 North America Surgical Treatment of Dermatophytosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Surgical Treatment of Dermatophytosis Market Size by Country (2020-2025)
6.4 North America Surgical Treatment of Dermatophytosis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Surgical Treatment of Dermatophytosis Market Size (2020-2031)
7.2 Europe Surgical Treatment of Dermatophytosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Surgical Treatment of Dermatophytosis Market Size by Country (2020-2025)
7.4 Europe Surgical Treatment of Dermatophytosis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Surgical Treatment of Dermatophytosis Market Size (2020-2031)
8.2 Asia-Pacific Surgical Treatment of Dermatophytosis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Surgical Treatment of Dermatophytosis Market Size by Region (2020-2025)
8.4 Asia-Pacific Surgical Treatment of Dermatophytosis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Surgical Treatment of Dermatophytosis Market Size (2020-2031)
9.2 Latin America Surgical Treatment of Dermatophytosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Surgical Treatment of Dermatophytosis Market Size by Country (2020-2025)
9.4 Latin America Surgical Treatment of Dermatophytosis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Surgical Treatment of Dermatophytosis Market Size (2020-2031)
10.2 Middle East & Africa Surgical Treatment of Dermatophytosis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Surgical Treatment of Dermatophytosis Market Size by Country (2020-2025)
10.4 Middle East & Africa Surgical Treatment of Dermatophytosis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Surgical Treatment of Dermatophytosis Introduction
11.1.4 Bausch Health Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.1.5 Bausch Health Recent Development
11.2 Galderma S.A.
11.2.1 Galderma S.A. Company Details
11.2.2 Galderma S.A. Business Overview
11.2.3 Galderma S.A. Surgical Treatment of Dermatophytosis Introduction
11.2.4 Galderma S.A. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.2.5 Galderma S.A. Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Surgical Treatment of Dermatophytosis Introduction
11.3.4 Novartis AG Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.3.5 Novartis AG Recent Development
11.4 Pfizer, Inc.
11.4.1 Pfizer, Inc. Company Details
11.4.2 Pfizer, Inc. Business Overview
11.4.3 Pfizer, Inc. Surgical Treatment of Dermatophytosis Introduction
11.4.4 Pfizer, Inc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.4.5 Pfizer, Inc. Recent Development
11.5 Moberg Pharma AB
11.5.1 Moberg Pharma AB Company Details
11.5.2 Moberg Pharma AB Business Overview
11.5.3 Moberg Pharma AB Surgical Treatment of Dermatophytosis Introduction
11.5.4 Moberg Pharma AB Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.5.5 Moberg Pharma AB Recent Development
11.6 Bayer AG
11.6.1 Bayer AG Company Details
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Surgical Treatment of Dermatophytosis Introduction
11.6.4 Bayer AG Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.6.5 Bayer AG Recent Development
11.7 Dr. Reddy’s Laboratories Ltd.
11.7.1 Dr. Reddy’s Laboratories Ltd. Company Details
11.7.2 Dr. Reddy’s Laboratories Ltd. Business Overview
11.7.3 Dr. Reddy’s Laboratories Ltd. Surgical Treatment of Dermatophytosis Introduction
11.7.4 Dr. Reddy’s Laboratories Ltd. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.7.5 Dr. Reddy’s Laboratories Ltd. Recent Development
11.8 Cipla Ltd.
11.8.1 Cipla Ltd. Company Details
11.8.2 Cipla Ltd. Business Overview
11.8.3 Cipla Ltd. Surgical Treatment of Dermatophytosis Introduction
11.8.4 Cipla Ltd. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.8.5 Cipla Ltd. Recent Development
11.9 Medimetriks Pharmaceuticals, Inc.
11.9.1 Medimetriks Pharmaceuticals, Inc. Company Details
11.9.2 Medimetriks Pharmaceuticals, Inc. Business Overview
11.9.3 Medimetriks Pharmaceuticals, Inc. Surgical Treatment of Dermatophytosis Introduction
11.9.4 Medimetriks Pharmaceuticals, Inc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.9.5 Medimetriks Pharmaceuticals, Inc. Recent Development
11.10 Sanofi S.A.
11.10.1 Sanofi S.A. Company Details
11.10.2 Sanofi S.A. Business Overview
11.10.3 Sanofi S.A. Surgical Treatment of Dermatophytosis Introduction
11.10.4 Sanofi S.A. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.10.5 Sanofi S.A. Recent Development
11.11 GlaxoSmithKline Plc.
11.11.1 GlaxoSmithKline Plc. Company Details
11.11.2 GlaxoSmithKline Plc. Business Overview
11.11.3 GlaxoSmithKline Plc. Surgical Treatment of Dermatophytosis Introduction
11.11.4 GlaxoSmithKline Plc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.11.5 GlaxoSmithKline Plc. Recent Development
11.12 Teva Pharmaceutical industries Ltd.
11.12.1 Teva Pharmaceutical industries Ltd. Company Details
11.12.2 Teva Pharmaceutical industries Ltd. Business Overview
11.12.3 Teva Pharmaceutical industries Ltd. Surgical Treatment of Dermatophytosis Introduction
11.12.4 Teva Pharmaceutical industries Ltd. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.12.5 Teva Pharmaceutical industries Ltd. Recent Development
11.13 Cardinal Health Inc.
11.13.1 Cardinal Health Inc. Company Details
11.13.2 Cardinal Health Inc. Business Overview
11.13.3 Cardinal Health Inc. Surgical Treatment of Dermatophytosis Introduction
11.13.4 Cardinal Health Inc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.13.5 Cardinal Health Inc. Recent Development
11.14 Viatris Inc.
11.14.1 Viatris Inc. Company Details
11.14.2 Viatris Inc. Business Overview
11.14.3 Viatris Inc. Surgical Treatment of Dermatophytosis Introduction
11.14.4 Viatris Inc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.14.5 Viatris Inc. Recent Development
11.15 Almirall, S.A
11.15.1 Almirall, S.A Company Details
11.15.2 Almirall, S.A Business Overview
11.15.3 Almirall, S.A Surgical Treatment of Dermatophytosis Introduction
11.15.4 Almirall, S.A Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025)
11.15.5 Almirall, S.A Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Surgical Treatment of Dermatophytosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Dermatophytic Onychomycosis Therapeutic Lasers
Table 3. Key Players of Photodynamic Therapy
Table 4. Global Surgical Treatment of Dermatophytosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Surgical Treatment of Dermatophytosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Surgical Treatment of Dermatophytosis Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Surgical Treatment of Dermatophytosis Market Share by Region (2020-2025)
Table 8. Global Surgical Treatment of Dermatophytosis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Surgical Treatment of Dermatophytosis Market Share by Region (2026-2031)
Table 10. Surgical Treatment of Dermatophytosis Market Trends
Table 11. Surgical Treatment of Dermatophytosis Market Drivers
Table 12. Surgical Treatment of Dermatophytosis Market Challenges
Table 13. Surgical Treatment of Dermatophytosis Market Restraints
Table 14. Global Surgical Treatment of Dermatophytosis Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Surgical Treatment of Dermatophytosis Market Share by Players (2020-2025)
Table 16. Global Top Surgical Treatment of Dermatophytosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Surgical Treatment of Dermatophytosis as of 2024)
Table 17. Ranking of Global Top Surgical Treatment of Dermatophytosis Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Surgical Treatment of Dermatophytosis Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Surgical Treatment of Dermatophytosis, Headquarters and Area Served
Table 20. Global Key Players of Surgical Treatment of Dermatophytosis, Product and Application
Table 21. Global Key Players of Surgical Treatment of Dermatophytosis, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Surgical Treatment of Dermatophytosis Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Surgical Treatment of Dermatophytosis Revenue Market Share by Type (2020-2025)
Table 25. Global Surgical Treatment of Dermatophytosis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Surgical Treatment of Dermatophytosis Revenue Market Share by Type (2026-2031)
Table 27. Global Surgical Treatment of Dermatophytosis Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Surgical Treatment of Dermatophytosis Revenue Market Share by Application (2020-2025)
Table 29. Global Surgical Treatment of Dermatophytosis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Surgical Treatment of Dermatophytosis Revenue Market Share by Application (2026-2031)
Table 31. North America Surgical Treatment of Dermatophytosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Surgical Treatment of Dermatophytosis Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Surgical Treatment of Dermatophytosis Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Surgical Treatment of Dermatophytosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Surgical Treatment of Dermatophytosis Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Surgical Treatment of Dermatophytosis Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Surgical Treatment of Dermatophytosis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Surgical Treatment of Dermatophytosis Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Surgical Treatment of Dermatophytosis Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Surgical Treatment of Dermatophytosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Surgical Treatment of Dermatophytosis Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Surgical Treatment of Dermatophytosis Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Surgical Treatment of Dermatophytosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Surgical Treatment of Dermatophytosis Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Surgical Treatment of Dermatophytosis Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bausch Health Company Details
Table 47. Bausch Health Business Overview
Table 48. Bausch Health Surgical Treatment of Dermatophytosis Product
Table 49. Bausch Health Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 50. Bausch Health Recent Development
Table 51. Galderma S.A. Company Details
Table 52. Galderma S.A. Business Overview
Table 53. Galderma S.A. Surgical Treatment of Dermatophytosis Product
Table 54. Galderma S.A. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 55. Galderma S.A. Recent Development
Table 56. Novartis AG Company Details
Table 57. Novartis AG Business Overview
Table 58. Novartis AG Surgical Treatment of Dermatophytosis Product
Table 59. Novartis AG Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 60. Novartis AG Recent Development
Table 61. Pfizer, Inc. Company Details
Table 62. Pfizer, Inc. Business Overview
Table 63. Pfizer, Inc. Surgical Treatment of Dermatophytosis Product
Table 64. Pfizer, Inc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 65. Pfizer, Inc. Recent Development
Table 66. Moberg Pharma AB Company Details
Table 67. Moberg Pharma AB Business Overview
Table 68. Moberg Pharma AB Surgical Treatment of Dermatophytosis Product
Table 69. Moberg Pharma AB Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 70. Moberg Pharma AB Recent Development
Table 71. Bayer AG Company Details
Table 72. Bayer AG Business Overview
Table 73. Bayer AG Surgical Treatment of Dermatophytosis Product
Table 74. Bayer AG Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 75. Bayer AG Recent Development
Table 76. Dr. Reddy’s Laboratories Ltd. Company Details
Table 77. Dr. Reddy’s Laboratories Ltd. Business Overview
Table 78. Dr. Reddy’s Laboratories Ltd. Surgical Treatment of Dermatophytosis Product
Table 79. Dr. Reddy’s Laboratories Ltd. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 80. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 81. Cipla Ltd. Company Details
Table 82. Cipla Ltd. Business Overview
Table 83. Cipla Ltd. Surgical Treatment of Dermatophytosis Product
Table 84. Cipla Ltd. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 85. Cipla Ltd. Recent Development
Table 86. Medimetriks Pharmaceuticals, Inc. Company Details
Table 87. Medimetriks Pharmaceuticals, Inc. Business Overview
Table 88. Medimetriks Pharmaceuticals, Inc. Surgical Treatment of Dermatophytosis Product
Table 89. Medimetriks Pharmaceuticals, Inc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 90. Medimetriks Pharmaceuticals, Inc. Recent Development
Table 91. Sanofi S.A. Company Details
Table 92. Sanofi S.A. Business Overview
Table 93. Sanofi S.A. Surgical Treatment of Dermatophytosis Product
Table 94. Sanofi S.A. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 95. Sanofi S.A. Recent Development
Table 96. GlaxoSmithKline Plc. Company Details
Table 97. GlaxoSmithKline Plc. Business Overview
Table 98. GlaxoSmithKline Plc. Surgical Treatment of Dermatophytosis Product
Table 99. GlaxoSmithKline Plc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 100. GlaxoSmithKline Plc. Recent Development
Table 101. Teva Pharmaceutical industries Ltd. Company Details
Table 102. Teva Pharmaceutical industries Ltd. Business Overview
Table 103. Teva Pharmaceutical industries Ltd. Surgical Treatment of Dermatophytosis Product
Table 104. Teva Pharmaceutical industries Ltd. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 105. Teva Pharmaceutical industries Ltd. Recent Development
Table 106. Cardinal Health Inc. Company Details
Table 107. Cardinal Health Inc. Business Overview
Table 108. Cardinal Health Inc. Surgical Treatment of Dermatophytosis Product
Table 109. Cardinal Health Inc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 110. Cardinal Health Inc. Recent Development
Table 111. Viatris Inc. Company Details
Table 112. Viatris Inc. Business Overview
Table 113. Viatris Inc. Surgical Treatment of Dermatophytosis Product
Table 114. Viatris Inc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 115. Viatris Inc. Recent Development
Table 116. Almirall, S.A Company Details
Table 117. Almirall, S.A Business Overview
Table 118. Almirall, S.A Surgical Treatment of Dermatophytosis Product
Table 119. Almirall, S.A Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 120. Almirall, S.A Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Surgical Treatment of Dermatophytosis Picture
Figure 2. Global Surgical Treatment of Dermatophytosis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Surgical Treatment of Dermatophytosis Market Share by Type: 2024 VS 2031
Figure 4. Dermatophytic Onychomycosis Therapeutic Lasers Features
Figure 5. Photodynamic Therapy Features
Figure 6. Global Surgical Treatment of Dermatophytosis Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Surgical Treatment of Dermatophytosis Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Surgical Treatment of Dermatophytosis Report Years Considered
Figure 12. Global Surgical Treatment of Dermatophytosis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Surgical Treatment of Dermatophytosis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Surgical Treatment of Dermatophytosis Market Share by Region: 2024 VS 2031
Figure 15. Global Surgical Treatment of Dermatophytosis Market Share by Players in 2024
Figure 16. Global Top Surgical Treatment of Dermatophytosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Surgical Treatment of Dermatophytosis as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Surgical Treatment of Dermatophytosis Revenue in 2024
Figure 18. North America Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Surgical Treatment of Dermatophytosis Market Share by Country (2020-2031)
Figure 20. United States Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Surgical Treatment of Dermatophytosis Market Share by Country (2020-2031)
Figure 24. Germany Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Surgical Treatment of Dermatophytosis Market Share by Region (2020-2031)
Figure 32. China Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Surgical Treatment of Dermatophytosis Market Share by Country (2020-2031)
Figure 40. Mexico Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Surgical Treatment of Dermatophytosis Market Share by Country (2020-2031)
Figure 44. Turkey Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Bausch Health Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 48. Galderma S.A. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 49. Novartis AG Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 50. Pfizer, Inc. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 51. Moberg Pharma AB Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 52. Bayer AG Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 53. Dr. Reddy’s Laboratories Ltd. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 54. Cipla Ltd. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 55. Medimetriks Pharmaceuticals, Inc. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 56. Sanofi S.A. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 57. GlaxoSmithKline Plc. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 58. Teva Pharmaceutical industries Ltd. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 59. Cardinal Health Inc. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 60. Viatris Inc. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 61. Almirall, S.A Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Surgical Treatment of Dermatophytosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Dermatophytic Onychomycosis Therapeutic Lasers
Table 3. Key Players of Photodynamic Therapy
Table 4. Global Surgical Treatment of Dermatophytosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Surgical Treatment of Dermatophytosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Surgical Treatment of Dermatophytosis Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Surgical Treatment of Dermatophytosis Market Share by Region (2020-2025)
Table 8. Global Surgical Treatment of Dermatophytosis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Surgical Treatment of Dermatophytosis Market Share by Region (2026-2031)
Table 10. Surgical Treatment of Dermatophytosis Market Trends
Table 11. Surgical Treatment of Dermatophytosis Market Drivers
Table 12. Surgical Treatment of Dermatophytosis Market Challenges
Table 13. Surgical Treatment of Dermatophytosis Market Restraints
Table 14. Global Surgical Treatment of Dermatophytosis Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Surgical Treatment of Dermatophytosis Market Share by Players (2020-2025)
Table 16. Global Top Surgical Treatment of Dermatophytosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Surgical Treatment of Dermatophytosis as of 2024)
Table 17. Ranking of Global Top Surgical Treatment of Dermatophytosis Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Surgical Treatment of Dermatophytosis Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Surgical Treatment of Dermatophytosis, Headquarters and Area Served
Table 20. Global Key Players of Surgical Treatment of Dermatophytosis, Product and Application
Table 21. Global Key Players of Surgical Treatment of Dermatophytosis, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Surgical Treatment of Dermatophytosis Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Surgical Treatment of Dermatophytosis Revenue Market Share by Type (2020-2025)
Table 25. Global Surgical Treatment of Dermatophytosis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Surgical Treatment of Dermatophytosis Revenue Market Share by Type (2026-2031)
Table 27. Global Surgical Treatment of Dermatophytosis Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Surgical Treatment of Dermatophytosis Revenue Market Share by Application (2020-2025)
Table 29. Global Surgical Treatment of Dermatophytosis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Surgical Treatment of Dermatophytosis Revenue Market Share by Application (2026-2031)
Table 31. North America Surgical Treatment of Dermatophytosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Surgical Treatment of Dermatophytosis Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Surgical Treatment of Dermatophytosis Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Surgical Treatment of Dermatophytosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Surgical Treatment of Dermatophytosis Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Surgical Treatment of Dermatophytosis Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Surgical Treatment of Dermatophytosis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Surgical Treatment of Dermatophytosis Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Surgical Treatment of Dermatophytosis Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Surgical Treatment of Dermatophytosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Surgical Treatment of Dermatophytosis Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Surgical Treatment of Dermatophytosis Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Surgical Treatment of Dermatophytosis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Surgical Treatment of Dermatophytosis Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Surgical Treatment of Dermatophytosis Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bausch Health Company Details
Table 47. Bausch Health Business Overview
Table 48. Bausch Health Surgical Treatment of Dermatophytosis Product
Table 49. Bausch Health Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 50. Bausch Health Recent Development
Table 51. Galderma S.A. Company Details
Table 52. Galderma S.A. Business Overview
Table 53. Galderma S.A. Surgical Treatment of Dermatophytosis Product
Table 54. Galderma S.A. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 55. Galderma S.A. Recent Development
Table 56. Novartis AG Company Details
Table 57. Novartis AG Business Overview
Table 58. Novartis AG Surgical Treatment of Dermatophytosis Product
Table 59. Novartis AG Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 60. Novartis AG Recent Development
Table 61. Pfizer, Inc. Company Details
Table 62. Pfizer, Inc. Business Overview
Table 63. Pfizer, Inc. Surgical Treatment of Dermatophytosis Product
Table 64. Pfizer, Inc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 65. Pfizer, Inc. Recent Development
Table 66. Moberg Pharma AB Company Details
Table 67. Moberg Pharma AB Business Overview
Table 68. Moberg Pharma AB Surgical Treatment of Dermatophytosis Product
Table 69. Moberg Pharma AB Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 70. Moberg Pharma AB Recent Development
Table 71. Bayer AG Company Details
Table 72. Bayer AG Business Overview
Table 73. Bayer AG Surgical Treatment of Dermatophytosis Product
Table 74. Bayer AG Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 75. Bayer AG Recent Development
Table 76. Dr. Reddy’s Laboratories Ltd. Company Details
Table 77. Dr. Reddy’s Laboratories Ltd. Business Overview
Table 78. Dr. Reddy’s Laboratories Ltd. Surgical Treatment of Dermatophytosis Product
Table 79. Dr. Reddy’s Laboratories Ltd. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 80. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 81. Cipla Ltd. Company Details
Table 82. Cipla Ltd. Business Overview
Table 83. Cipla Ltd. Surgical Treatment of Dermatophytosis Product
Table 84. Cipla Ltd. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 85. Cipla Ltd. Recent Development
Table 86. Medimetriks Pharmaceuticals, Inc. Company Details
Table 87. Medimetriks Pharmaceuticals, Inc. Business Overview
Table 88. Medimetriks Pharmaceuticals, Inc. Surgical Treatment of Dermatophytosis Product
Table 89. Medimetriks Pharmaceuticals, Inc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 90. Medimetriks Pharmaceuticals, Inc. Recent Development
Table 91. Sanofi S.A. Company Details
Table 92. Sanofi S.A. Business Overview
Table 93. Sanofi S.A. Surgical Treatment of Dermatophytosis Product
Table 94. Sanofi S.A. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 95. Sanofi S.A. Recent Development
Table 96. GlaxoSmithKline Plc. Company Details
Table 97. GlaxoSmithKline Plc. Business Overview
Table 98. GlaxoSmithKline Plc. Surgical Treatment of Dermatophytosis Product
Table 99. GlaxoSmithKline Plc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 100. GlaxoSmithKline Plc. Recent Development
Table 101. Teva Pharmaceutical industries Ltd. Company Details
Table 102. Teva Pharmaceutical industries Ltd. Business Overview
Table 103. Teva Pharmaceutical industries Ltd. Surgical Treatment of Dermatophytosis Product
Table 104. Teva Pharmaceutical industries Ltd. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 105. Teva Pharmaceutical industries Ltd. Recent Development
Table 106. Cardinal Health Inc. Company Details
Table 107. Cardinal Health Inc. Business Overview
Table 108. Cardinal Health Inc. Surgical Treatment of Dermatophytosis Product
Table 109. Cardinal Health Inc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 110. Cardinal Health Inc. Recent Development
Table 111. Viatris Inc. Company Details
Table 112. Viatris Inc. Business Overview
Table 113. Viatris Inc. Surgical Treatment of Dermatophytosis Product
Table 114. Viatris Inc. Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 115. Viatris Inc. Recent Development
Table 116. Almirall, S.A Company Details
Table 117. Almirall, S.A Business Overview
Table 118. Almirall, S.A Surgical Treatment of Dermatophytosis Product
Table 119. Almirall, S.A Revenue in Surgical Treatment of Dermatophytosis Business (2020-2025) & (US$ Million)
Table 120. Almirall, S.A Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Surgical Treatment of Dermatophytosis Picture
Figure 2. Global Surgical Treatment of Dermatophytosis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Surgical Treatment of Dermatophytosis Market Share by Type: 2024 VS 2031
Figure 4. Dermatophytic Onychomycosis Therapeutic Lasers Features
Figure 5. Photodynamic Therapy Features
Figure 6. Global Surgical Treatment of Dermatophytosis Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Surgical Treatment of Dermatophytosis Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Surgical Treatment of Dermatophytosis Report Years Considered
Figure 12. Global Surgical Treatment of Dermatophytosis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Surgical Treatment of Dermatophytosis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Surgical Treatment of Dermatophytosis Market Share by Region: 2024 VS 2031
Figure 15. Global Surgical Treatment of Dermatophytosis Market Share by Players in 2024
Figure 16. Global Top Surgical Treatment of Dermatophytosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Surgical Treatment of Dermatophytosis as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Surgical Treatment of Dermatophytosis Revenue in 2024
Figure 18. North America Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Surgical Treatment of Dermatophytosis Market Share by Country (2020-2031)
Figure 20. United States Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Surgical Treatment of Dermatophytosis Market Share by Country (2020-2031)
Figure 24. Germany Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Surgical Treatment of Dermatophytosis Market Share by Region (2020-2031)
Figure 32. China Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Surgical Treatment of Dermatophytosis Market Share by Country (2020-2031)
Figure 40. Mexico Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Surgical Treatment of Dermatophytosis Market Share by Country (2020-2031)
Figure 44. Turkey Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Surgical Treatment of Dermatophytosis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Bausch Health Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 48. Galderma S.A. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 49. Novartis AG Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 50. Pfizer, Inc. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 51. Moberg Pharma AB Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 52. Bayer AG Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 53. Dr. Reddy’s Laboratories Ltd. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 54. Cipla Ltd. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 55. Medimetriks Pharmaceuticals, Inc. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 56. Sanofi S.A. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 57. GlaxoSmithKline Plc. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 58. Teva Pharmaceutical industries Ltd. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 59. Cardinal Health Inc. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 60. Viatris Inc. Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 61. Almirall, S.A Revenue Growth Rate in Surgical Treatment of Dermatophytosis Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232